Preventing blindness by

improving retinal therapy

AI tools to empower ophthalmologists

Our Vision

Preventing blindness by improving retinal therapy

deepeye empowers ophthalmologists to provide individual therapy to patients suffering from retinal eye diseases like Age-related Macular Degeneration (AMD) and others with a prevalence of >12% in the European and US population, thus preventing the causes of more than 90% of blindness‘.

Our Approach

Treatment of retinal diseases is complex, costly and hardly allows individual treatment of patients.

By developing AI tools for ophthalmology, we plan to significantly improve the therapy process for patients and doctors.

This enables individualized patient care and even more successful therapy outcomes.

Our Solution

The digital therapy assistant

deepeye develops therapy decision support systems for ophthalmologists. Based on high quality retinal images (OCTs), our deep learning models provide a 2nd opinion on the current therapy need and future appointments.

We have been awarded

Winner of the German
AI Award 2020

In 2020, the DeepEye project received the German AI Application Award, an award by WELT for outstanding achievements in the practical application of AI. This pushed us to found deepeye Medical to go through clinical evaluation and then bring this solution to market.

We have been awarded

Winner 2nd place
Health-i Award 2021

At the Health-i Award from Techniker Krankenkasse and Handelsblatt, we took 2nd place for our AI-powered therapy assistant for ophthalmologists. We thus were able to prevail among 200 ideas and companies. Many thanks for the great feedback from the jury and other participants!

deepeye is

supported by

Contact us

Interested in what happens next?

12 + 11 =